JP2010526049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526049A5 JP2010526049A5 JP2010504887A JP2010504887A JP2010526049A5 JP 2010526049 A5 JP2010526049 A5 JP 2010526049A5 JP 2010504887 A JP2010504887 A JP 2010504887A JP 2010504887 A JP2010504887 A JP 2010504887A JP 2010526049 A5 JP2010526049 A5 JP 2010526049A5
- Authority
- JP
- Japan
- Prior art keywords
- epo
- csf
- combination according
- subject
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003951 Erythropoietin Human genes 0.000 claims 10
- 108090000394 Erythropoietin Proteins 0.000 claims 10
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 10
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 10
- 229940105423 erythropoietin Drugs 0.000 claims 10
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 10
- 208000026106 cerebrovascular disease Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 206010008118 cerebral infarction Diseases 0.000 claims 1
- 238000011284 combination treatment Methods 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/703,578 | 2007-02-07 | ||
| US11/703,578 US7618938B2 (en) | 2007-02-07 | 2007-02-07 | Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly |
| PCT/IB2008/000740 WO2009122227A2 (en) | 2007-02-07 | 2008-02-07 | Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010526049A JP2010526049A (ja) | 2010-07-29 |
| JP2010526049A5 true JP2010526049A5 (enExample) | 2011-03-24 |
| JP5291089B2 JP5291089B2 (ja) | 2013-09-18 |
Family
ID=39676682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010504887A Expired - Fee Related JP5291089B2 (ja) | 2007-02-07 | 2008-02-07 | エリスロポエチンと顆粒球コロニー刺激因子とを組み合わせてなる医薬及び同医薬の製造におけるエリスロポエチン及び顆粒球コロニー刺激因子の使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7618938B2 (enExample) |
| EP (1) | EP2139510B1 (enExample) |
| JP (1) | JP5291089B2 (enExample) |
| TW (1) | TWI327473B (enExample) |
| WO (1) | WO2009122227A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1019082B2 (en) * | 1997-10-02 | 2008-06-04 | Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. | Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| AU2012225784B2 (en) | 2011-03-04 | 2016-03-17 | The Regents Of The University Of California | Locally released growth factors to mediate motor recovery after stroke |
| US20160015786A1 (en) * | 2013-03-01 | 2016-01-21 | Mater Medical Research Institute Limited | Mobilizing agents and uses therefor |
| US20210179721A1 (en) * | 2017-11-29 | 2021-06-17 | Csl Limited | Method of treating or preventing ischemia-reperfusion injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU229475B1 (en) * | 2001-12-06 | 2014-01-28 | Fibrogen | Methods of increasing endogenous erythropoietin (epo) |
| US7785601B2 (en) * | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| US7220407B2 (en) * | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| AU2005306894B2 (en) * | 2004-11-05 | 2011-11-24 | Northwestern University | Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders |
-
2007
- 2007-02-07 US US11/703,578 patent/US7618938B2/en active Active
- 2007-08-14 TW TW096129950A patent/TWI327473B/zh not_active IP Right Cessation
-
2008
- 2008-02-07 EP EP08873034.6A patent/EP2139510B1/en not_active Not-in-force
- 2008-02-07 JP JP2010504887A patent/JP5291089B2/ja not_active Expired - Fee Related
- 2008-02-07 WO PCT/IB2008/000740 patent/WO2009122227A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525444A5 (enExample) | ||
| JP2014530220A5 (enExample) | ||
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| JP2007527914A5 (enExample) | ||
| JP2007504174A5 (enExample) | ||
| JP2010515715A5 (enExample) | ||
| JP2012511510A5 (enExample) | ||
| HK1200716A1 (zh) | 使用胞苷類似物的口服製劑治療癌症的方法 | |
| JP2010059183A5 (enExample) | ||
| JP2009500443A5 (enExample) | ||
| JP2006526626A5 (enExample) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| WO2009065406A3 (en) | Novel cyclic hydrocarbon compounds for the treatment of diseases | |
| EP2257280A4 (en) | TECHNICALLY MANIPULATED TUNABLE NANOTEHICLES FOR THE DELIVERY OF THERAPEUTIC, DIAGNOSTIC AND EXPERIMENTAL COMPOUNDS AND RELEVANT COMPOSITIONS FOR THERAPEUTIC USE | |
| CL2008001921A1 (es) | Compuestos derivados de heterociclos sustituidos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como ictus, isquemia cerebral, alzheimer, dolor, entre otras. | |
| CN104812762A8 (en) | Substituted annulated pyrimidines and triazines, and use thereof | |
| EP3309555A3 (en) | Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation | |
| MX2011008944A (es) | Tratamiento de trastornos relacionados con la discinesia. | |
| WO2009029622A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
| EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
| JP2015500223A5 (enExample) | ||
| WO2006053049A3 (en) | Herbal composition phy906 and its use in chemotherapy | |
| JP2016530291A5 (enExample) | ||
| JP2015512420A5 (enExample) | ||
| EA200901237A1 (ru) | Применение димирацетама при лечении хронической боли |